March 2025 FDA Recall Voriconazole by Amerisource Health Services Llc
D-0307-2025 - cGMP Deviations

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on March 24, 2025 for the product Voriconazole. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0307-2025

Reason for Recall
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Initiated
03-24-2025
Reported
04-09-2025
Quantity
889 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.

Batch or Lot Expiration Information

Lot# 1014138, Exp 04/30/2025